NTHI vs TLRY · rev $40.0K vs rev $915.5M
NeOnc Technologies Holdings, Inc. Common Stock (NTHI) versus Tilray Inc (TLRY) — a side-by-side from cached financials, not a winner call.
NeOnc Technologies Holdings, Inc. Common Stock (NTHI) is a biotechnology company listed on NASDAQ.
Tilray Inc (TLRY) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported NTHI revenue for 2025-12-31 was $40.0K. Net income was -$62.1M. Revenue was down 51.8% from 2024-12-31 to 2025-12-31. NTHI currently screens at market cap $117.3M.
Latest reported TLRY revenue for 2026-05-31 was $915.5M. Net income was -$121.4M. Revenue was up 11.5% from 2025-05-31 to 2026-05-31. TLRY currently screens at market cap $573.9M.
NTHI currently screens at market cap $117.3M. TLRY currently screens at market cap $573.9M.
Not investment advice. Open the NTHI and TLRY stock pages for the full models.
Not investment advice.